Browsing by Author Hogg, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2008A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)Mann, Graham; Badenase, Celia; Bergman, Wilma; et al, Not Known; Goldstein, Alisa M; Gruis, Nelleke; Harland, Mark; Hayward, Nicholas; Hogg, David; Kukalizch, Kairen; Puig, Susana; Taylor, Claire F; ter Huurnef, Jeanet; Western Clinical School: Westmead Millennium InstituteA comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL), European Journal of Cancer, vol.44,(9),2008,pp 1269-1274
2017Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialLong, Georgina; Arance, Ana; Chiarion-Sileni, Vanna; Davies, Michael; Del Vecchio, M; Flaherty, Keith; Grob, Jean-Jacques; Hogg, David; Huang, Yingjie; Lebbe, Celeste; Lesimple, Thierry; Márquez-Rodas, Ivan; Meyer, Nicolas; Mookerjee, Bijoyesh P; Mortier, Laurent; Moschos, S; Robert, Caroline; Saiag, Philippe; Thomas, Luc; Zhang, Ying; Northern Clinical School: MedicineDabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial, The Lancet Oncology, vol.18, 7, 2017,pp 863-873
2006Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents.Holland, Elizabeth; Kefford, Richard (Rick); Mann, Graham; Azizi, Esther; Bergman, Wilma; Bianchi-Scarra, Giovanna; Bishop, D.Timothy; Bruno, William; Calista, Donato; Cannon Albright, Lisa A; Chan, May; Chaudru, Valerie; Chompret, Agnes; Cuellar, Francisco; Demenais, Florence; Elder, David E; Ghiorzo, Paola; Gillanders, E. M.; Goldstein, Alisa M; Gruis, Nelleke; Hansson, Johan; Harland, Mark; Hayward, Nicholas; Hogg, David; Kanetsky, Peter A.; Landi, Maria Teresa; Lang, Julie; Leachman, Sancy A; Mackie, R; Magnusson, Veronica; Newton, B s; Palmer, Jane; Puig, Susana; Puig-Butille, Joan A; Stark, Mitchell; The Lund Melanoma Study Group, Stockholm; Tsao, Hensin; Tucker, Margaret A; Whitaker, Linda; Yakobson, Emanuel; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteFeatures associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents., Journal of Medical Genetics, vol.44,(2),2006,pp 99-106
2006High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.Holland, Elizabeth; Kefford, Richard (Rick); Mann, Graham; Avril, Marie-Francoise; Azizi, Esther; Bianchi-Scarra, Giovanna; Bishop, D Timothy; Bressac-de Paillerets, Brigitte; Bruno, William; Calista, Donato; Cannon Albright, Lisa A; Chan, May; de Snoo, Femke A; Demenais, Florence; Elder, David E; Ghiorzo, Paola; Gillanders, E; Goldstein, Alisa; Gruis, Nelleke; Hansson, Johan; Harland, Mark; Hayward, N.K.; Hogg, David; Kanetsky, Peter A.; Landi, Maria Teresa; Lang, Julie; Leachman, Sancy A; Mackie, Rona; Magnusson, Veronica; Newton Bishop, Julia A; Niendorf, Kristin; Palmer, Jane; Puig, Susana; Puig-Butille, Joan A; Stark, Mitchell; The Lund Melanoma Study Group, Stockholm; Tsao, Hensin; Tucker, Margaret A; Whitaker, Linda; Yakobson, Emanuel; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteHigh-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL., Cancer Research 2005, vol.66,(20),2006,pp 9818-9828